title: Trends in the survival of patients diagnosed with cancers in the respiratory system in the Nordic countries 1964-2003 followed up to the end of 2006.
abstract: BACKGROUND
  Previous studies have shown that there have been systematic differences between the Nordic countries in population-based relative survival of patients with respiratory cancer (lung, pleura, larynx, nose and sinuses).
  
  
  METHODS
  Relative survival of patients with respiratory cancer diagnosed in the Nordic countries in 1964-2003 and followed up to the end of 2006 was studied and contrasted with developments in incidence and mortality.
  
  
  RESULTS
  For cancer of the lung, relative survival is lower in Danish patients than in the other countries during the first months of follow-up after diagnosis. For cancer of pleura, the relative survival ratios indicate that there may be problems in the official coding of the causes of death in Denmark, Norway and Sweden. There has been little improvement in survival of patients with cancer of the respiratory organs in the Nordic countries over time.
  
  
  CONCLUSIONS
  The slightly lower survival of Danish lung cancer patients may be related to a less favourable stage distribution and to an increased prevalence of causal factors, affecting the mortality due to competing risks of death. A reclassification of official causes of death at the cancer registry may be needed for cancer of the pleura in order to make the corresponding mortality rates comparable between countries.
authors.affiliation: Finnish Cancer Registry, Pieni Roobertinkatu 9, Helsinki, Finland. timo.hakulinen@cancer.fi
authors.forename: Timo
authors.initials: T
authors.lastname: Hakulinen
authors.forename: Gerda
authors.initials: G
authors.lastname: Engholm
authors.forename: Mette
authors.initials: M
authors.lastname: Gislum
authors.forename: Hans H
authors.initials: HH
authors.lastname: Storm
authors.forename: Asa
authors.initials: A
authors.lastname: Klint
authors.forename: Laufey
authors.initials: L
authors.lastname: Tryggvadóttir
authors.forename: Freddie
authors.initials: F
authors.lastname: Bray
mesh_terms: D000328:Adult; D017677:Age Distribution; D000368:Aged; D000369:Aged, 80 and over; D003718:Denmark / Q000453:epidemiology; D005260:Female; D005387:Finland / Q000453:epidemiology; D005500:Follow-Up Studies; D006801:Humans; D007055:Iceland / Q000453:epidemiology; D015994:Incidence; D007822:Laryngeal Neoplasms / Q000401:mortality; D008175:Lung Neoplasms / Q000401:mortality; D008297:Male; D008875:Middle Aged; D009026:Mortality / Q000639:trends; D009664:Norway / Q000453:epidemiology; D009669:Nose Neoplasms / Q000401:mortality; D010255:Paranasal Sinus Neoplasms / Q000401:mortality; D010997:Pleural Neoplasms / Q000401:mortality; D012042:Registries; D012142:Respiratory Tract Neoplasms / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000401:mortality* / Q000628:therapy; D012307:Risk Factors; D017678:Sex Distribution; D016019:Survival Analysis; D015996:Survival Rate / Q000639:trends; D013548:Sweden / Q000453:epidemiology